Backup ventilation timing after apnoea in extremely preterm infants on nCPAP
This was a randomized cross-over trial in a single Level 3 neonatal intensive care unit. The population was 24 enrolled extremely preterm infants <28 weeks on nasal continuous positive airway pressure (nCPAP) with backup ventilation (BUV); 22 completed the study. The intervention was start of backup ventilation after 4 seconds of apnoea duration (AD 4), and the comparator was start after 16 seconds (AD 16).
The primary outcome was time spent within predefined oxygen saturation (SpO2) target (88%-95% or ≥88% with FiO2=0.21). There was no difference between AD 4 and AD 16: 66.9% vs 67.2% (p=0.88). The rate of BUV was significantly higher during AD 4, but absolute numbers and effect size were not reported.
Safety events were not reported, though 2 out of 24 infants did not complete the study. Key limitations include single-centre design, small sample size, and potential carryover effects from the cross-over design. The practice relevance is that reducing apnoea duration before backup ventilation did not improve time within SpO2 target in this population. Results show association, not causation for clinical outcomes, and certainty is limited by sample size and single-centre setting.